QIAGEN receives U.S. FDA emergency use authorization to analyze over 30 samples per hour
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The data should be submitted by August 12th 2021
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
Complementary business models are the reason for the acquisition
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Subscribe To Our Newsletter & Stay Updated